Dyslipidemia in an HIV-positive antiretroviral treatment-naive population in Dar es Salaam, Tanzania

J Acquir Immune Defic Syndr. 2011 Jun 1;57(2):141-5. doi: 10.1097/QAI.0b013e318219a3d1.

Abstract

Limited data are available on dyslipidemia in HIV-infected patients in resource-limited settings. We performed a cross-sectional analysis in antiretroviral therapy (ART)-naive, non-fasting HIV-infected patients in Tanzania between November 2004 to June 2008. Robust linear regression modeling was performed. Lipid parameters were assessed in 12,513 patients [65% women; median (interquartile range) age, 36 (30-42) years; CD4 count, 143 (51-290) cells/mm]. Low high-density lipoprotein was prevalent in 67% and increased triglyceride in 28%. High triglyceride and low high-density lipoprotein levels were associated with low CD4 counts (P < 0.001). In this ART-naive Tanzanian population, dyslipidemia was highly prevalent and associated with advanced disease. The impact of ART on these changes requires further exploration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / administration & dosage*
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • Cholesterol / blood
  • Cross-Sectional Studies
  • Dyslipidemias / epidemiology
  • Dyslipidemias / etiology*
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • Humans
  • Lipoproteins, HDL / blood
  • Lipoproteins, LDL / blood
  • Male
  • Prevalence
  • Tanzania / epidemiology
  • Triglycerides / blood

Substances

  • Anti-HIV Agents
  • Lipoproteins, HDL
  • Lipoproteins, LDL
  • Triglycerides
  • Cholesterol